Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 15/20 | 0.42 |
| ▸ | HTR2A | P28223 | 15/20 | 0.42 |
| ▸ | DRD3 | P35462 | 15/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7484230 | 0.82 | HTR1D (0.55) | DRD2 | |
| SCHEMBL8547100 | 0.81 | DRD2 (0.43) | DRD2HTR2ADRD3 | |
| SCHEMBL8550072 | 0.78 | MAPT (0.44) | DRD2HTR2ADRD3 | |
| SCHEMBL8547695 | 0.78 | DRD2 (0.42) | DRD2HTR2ADRD3NAMPT | |
| SCHEMBL8703395 | 0.77 | DRD2 (0.61) | DRD2HTR2ADRD3 | |
| SCHEMBL8549816 | 0.76 | L3MBTL1 (0.49) | — | |
| SCHEMBL8704542 | 0.76 | ALDH1A1 (0.53) | DRD2HTR2ADRD3 | |
| SCHEMBL8707882 | 0.75 | DRD2 (0.54) | DRD2HTR2ADRD3 | |
| SCHEMBL8703719 | 0.75 | DRD2 (0.53) | DRD2HTR2ADRD3 | |
| Hydrochloric Acid SCHEMBL8549247 | 0.74 | TP53 (0.46) | DRD2HTR2ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5792763-A | MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-08-11 | — | — | US | disclosed |
| WO-1998015545-A1 | NEW SEROTONIN 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 1998-04-16 | — | — | WO | disclosed |
| EP-0835869-A2 | New serotonin 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 1998-04-15 | — | — | EP | disclosed |